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Abstract
We aimed to elucidate prevalence and association of diabetic retinopathy (DR) in 
patients with diabetic foot ulcer (DFU) from Pakistan. In this cross-sectional study, 
about 225 DFU patients who underwent ophthalmic examinations within 6 months 
of diagnosis of foot ulceration were included. The medical records of 305 diabetic 
patients without DFU were included as controls. The association of DR with DFU was 
assessed by comparing DFU patients with proliferative DR (PDR) and DFU patients 
without PDR. Out of 225 DFU patients, 215 patients (95.6%) had DR and 169 patients 
(75.1%) had PDR. The prevalence of DFU was significantly greater (P = 0.0527) 
among the male diabetic patients, whereas advanced age of these patients (≥41 years) 
had a significant effect (P = 0.0286) on development and progression of PDR. A lon-
ger duration of diabetes (≥10 years) was identified as a significant contributing factor 
for the development of both DFU (P = 0.0029) and PDR (P = 0.0299). Moreover, 
the risk of PDR increased in diabetic patients with higher DFU grades (grade 3 and 
grade 4). In conclusion, retinopathy was prevalent in DFU patients. Therefore, DFU 
patients with advancing age and longer duration of diabetes should undergo retinal 
examinations for timely diagnosis and management of DR.
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1. Introduction
Diabetes mellitus (DM) is a metabolic disease, caused by chronic hyperglyce-
mia as a result of defects in secretion of insulin, resistance to insulin action, or a 
combination of the two. Type 1 and type 2 are two main types of diabetes. Type 1 
diabetes mellitus (T1DM) results from absolute deficiency of insulin secretion, and 
type 2 diabetes mellitus (T2DM) results from combined defects in both relative 
deficiency of insulin secretion and insulin resistance [1]. T2DM is the dominant 
form of diabetes which account to approximately >85% of all diabetes cases [2]. 
Diabetic foot ulcer (DFU) is the most devastating complication of diabetes, with a 
global prevalence of 6.3%, and is more common in patients with type 2 diabetes [3]. 
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The lifetime risk of foot ulceration in patients with diabetes lies somewhere in the 
range of 15 and 25% [4, 5], with a yearly rate of around 2–3% [6].
Diabetic is associated with microvascular complications, including retinopathy, 
neuropathy, and nephropathy, and macrovascular complications, including ischemic 
coronary illness, stroke, and peripheral vascular disease [7]. Diabetic retinopathy (DR) 
is a common complication of diabetes that affects vision. DR damages the blood vessels 
of the light-sensitive tissue at the back of the eye (retina) that results in blindness if left 
undiagnosed and untreated. It is estimated that 20 years after diagnosis, those with type 
1 diabetes and 60% of those with type 2 diabetes will have some level of retinopathy 
[8]. Approximately 4 million individuals around the globe are estimated to losing their 
sight from diabetic retinopathy, the main source of visual impairment in patients aged 
20–74 years [9]. The risk of development and progression of DR is closely associated 
with the type 1 diabetes [8], longer duration of diabetes [10], advancing age [11], poor 
glycemic control [12], high blood pressure [13] and elevated serum lipids [14].
The descriptive analytical studies have demonstrated that diabetic retinopathy 
(DR) is among one of the major contributing factors in the development of foot 
ulceration and subsequent lower limb amputation in diabetic patients [11, 15–17]. 
Importantly, DFU patients with PAD are less likely to heal and more likely to require 
amputation compared to patients without PAD. Moreover, retinal screening in people 
with diabetic foot ulceration, followed by treatment of sight-threatening retinopathy, 
may prevent severe vision loss or blindness [18]. It is therefore essential that DR is 
diagnosed in all diabetic patients with a foot ulcer. There is a significant rise in the 
prevalence of diabetes and its complications in Pakistan, causing a major social and 
economic burden [19, 20]. Therefore, this study was conducted with an aim to inves-
tigate the prevalence of DR in patients with a DFU in Pakistan and to elucidate the 
potential association between DR and DFU.
2. Materials and methods
This was a cross-sectional observational study conducted in the diabetology 
clinic at Pakistan Institute of Medical Sciences (PIMS), located in federal capital 
of Pakistan, which is the largest tertiary care referral hospital. This study was 
conducted between March 2017 and February 2018 as per the guidelines of the 
Declaration of Helsinki, and the Institutional Ethical Committee approval was 
obtained before initiation. The study was explained, and written informed consent 
of the patients was obtained before their recruitment. Inclusion criteria were as 
follows: (1) all type 2 diabetic patients and only those type 1 diabetes patients with 
diabetes duration of more than 5 years, diagnosed with foot ulcers based on the 
Wagner ulcer classification, were included in this study. (2) Patients were included 
in the study only if they underwent ophthalmic examinations particularly fundus-
copy of the retina within 6 months after DFU diagnosis.
Participated DFU patients were classified into Wagner’s grades [21] as follows: 
grade 1 (superficial ulcer), grade 2 (deep ulcer), grade 3 (ulcer with osteomyeli-
tis), grade 4 (forefoot gangrene), and grade 5 (mid foot or hind foot gangrene). 
Moreover, the presence and severity of DR among DFU patients were assessed 
based on the grading of the Global Diabetic Retinopathy Project Group [22]. A 
five-stage disease severity classification for DR includes no apparent retinopathy 
(no DR), proliferative DR (PDR), and mild, moderate, or severe non-proliferative 
DR (NPDR). Clinical information and demographic details were obtained from 
medical records of participating patients. The medical records of diabetic patients 
without a DFU who also visited the diabetology clinic at PIMS for a health checkup 
were included as control.
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Analysis of recruitment data was performed by using SPSS-PC version 16.0, 
and then tables and graphs were constructed to display characteristics of studied 
patients. The association between DR and DF was determined by using the Chi-
square test. P-values <0.05 were considered significant.
3. Results
Data of patients recruited in the study was analyzed and summarized in 
Table 1. Among 225 patients with foot ulceration, majority of them were male 
(62.7%) and had type 2 (60%) diabetes. Most DFU patients were aged 41 years 
old and over (88.4%) and had diabetes since ≥10 years (65.8%), high HbA1c ≥ 7% 
(77.3%), and higher level of systolic blood pressure (72.4%). Statistically, sig-
nificant differences were observed among diabetic patients with a foot ulcer or 
without a foot ulcer in relation to gender (P = 0.0527) and diabetes duration 
(P = 0.0029) only.
Additionally, DFU patients with PDR were compared with DFU patients 
without PDR as shown in Table 1. The PDR was less prevalent in diabetic males 
with foot ulcers (53.8%) in comparison to those without foot ulcers (66.1%). The 
DFU patients with PDR had type 2 diabetes (66.9%), advanced age (82.8%), longer 
Characteristics 
of patients
Diabetes (N = 530) P value DFU (N = 225) P value
Diabetes 
with DFU 
(N = 225)
Diabetes 
without 
DFU 
(N = 305)
DFU 
with PDR 
(N = 169)
DFU 
without
PDR
(N = 56)
Gender
Male 141 (62.7) 215 (70.5) 0.0527* 91 (53.8) 37 (66.1) 0.1024
Female 84 (37.3) 90 (29.5) 78 (46.2) 19 (33.9)
Age (years)
≤41 26 (11.6) 37 (12.1) 0.7084 29 (17.2) 19 (33.9) 0.0286*
≥41 199 (88.4) 268 (87.9) 140 (82.8) 37 (66.1)
Duration of diabetes (years)
≤10 77 (34.2) 135 (44.3) 0.0029* 24 (14.2) 17 (30.4) 0.0299*
≥10 148 (65.8) 170 (55.7) 145 (85.8) 39 (69.6)
Type of diabetes
Type 1 90 (40) 111 (36.4) 0.3352 56 (33.1) 22 (39.3) 0.4170
Type 2 135 (60) 194 (63.6) 113 (66.9) 34 (60.7)
HbA1c level
≤ 7% 51 (22.7) 95 (31.1) 0.1638 30 (17.8) 11 (19.6) 0.7577
≥ 7% 174 (77.3) 210 (68.9) 139 (82.2) 45 (80.4)
Blood pressure (mmHg)
Systolic 163 (72.4) 229 (75.1) 0.4882 122 (72.2) 41 (73.2) 0.8807
Diastolic 62 (27.6) 76 (24.9) 47 (27.8) 15 (26.8)
*Statistically significant
Table 1. 
Basic characteristics of diabetic patients with or without diabetic foot ulcer (DFU).
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duration of diabetes (85.8), high HbA1c ≥ 7% (82.2%), and elevated systolic blood 
pressure (72.2%) than DFU patients without PDR. The significant contributing 
factors of PDR among DFU patients were advanced age (p = 0.0286) and longer 
duration of diabetes (0.0299).
In terms of DR among diabetic patients with foot ulceration, 215 patients 
(95.6%) had DR and 169 patients (75.1%) had PDR. 11 patients (4.9%) had mild 
NPDR, 26 patients had moderate NPDR (11.6%), and 9 patients had severe NPDR 
(4.0%), as shown in Table 2 and Figure 1. Moreover, the common ulcer grades were 
3 (41.8%) and 4 (31.6%), among DFU patients with DR (Table 3).
Types of DR Diabetics with a DFU, 
N = 225(%)
Diabetics without a DFU, N = 305 (%)
No DR 10 (4.4) 255 (83.6)
Mild NPDR 11 (4.9) 10 (3.2)
Moderate NPDR 26 (11.6) 16 (5.2)
Severe NPDR 9 (4.0) 7 (2.3)
PDR 169 (75.1) 17 (5.6)
Table 2. 
Prevalence of DR in patients with a DFU and in diabetic patients without a DFU .
Figure 1. 
Fundus photographs of some studied patients show clinical grades of DR. (A) Mild NPDR phenotypes 
based on the presence of only two microaneurysms and the absence of macular edema. (B) Moderate NPDR 
phenotypes based on the presence of scattered microaneurysms, dot-blot hemorrhages, hard exudates, and 
diffuse macular edema. (C) Severe NPDR phenotypes based on the presence of scattered microaneurysms, 
dot-blot hemorrhages, hard exudates, cotton wool spots, and clinically significant macular edema. (D) 
PDR phenotypes based on the presence of new vessels on the disc (NVD), new vessels elsewhere (NVE), 
preretinal hemorrhage, retinal hemorrhages, tractional bands, and laser marks of the previous pan retinal 
photocoagulation (PRP).
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4. Discussion
Diabetes is a common disease, associated with microvascular and macrovascular 
diseases that contribute to an increased risk of foot ulcers and subsequent lower 
extremity amputations in diabetic patients [7]. Population-based studies identified 
that DR is among one of the contributing diseases that significantly increased risk 
for foot ulceration in diabetic populations of Saudi Arabia [23], Korea [11], Spain 
[15], Iran [16] and India [17]. However, data is limited about contribution of DR in 
development of foot ulceration in diabetic population of Pakistan.
The present study revealed that the majority (95.7%) of DFU patients had DR, 
with 71.9% demonstrated PDR. A similar study reported that DR was prevalent 
(90%) in the US diabetic patients with foot ulcers, and about more than half of 
these patients had PDR [11]. Pemayun et al. in a hospital-based case-control study 
found PAD to be a major predictive factor for poor outcome among hospitalized 
DFU patients [24]. Previously, Nwanyanwu et al. in a retrospective cohort study 
assessed that chronic foot ulcers might contribute to retinopathy progression due 
to the reason that a significant proportion of diabetic chronic ulcer patients with 
NPDR who progressed to PDR in their analysis [25]. Among DFU patients with 
PDR, 73.4% had advanced Wagner’s grades (grades 3 and 4) of foot ulceration in 
the present study. Hwang et al. found association of PDR with DFU and speculated 
that elevated oxidative stress and endothelial dysfunction can cause PDR in the 
advanced stages of diabetes [11].
The cross-sectional diabetes studies reported that prevalence of foot complica-
tions increases among diabetic males with advanced age and longer duration of 
diabetes [10, 11, 19, 23]. In the current study, diabetic patients with foot ulcers were 
compared with those without foot ulcers to find significant determinants for foot 
ulcer in diabetic patients, and it was found that a significant number of diabetic 
males were at a greater risk for the development of foot ulcers. Higher average 
height, higher plantar pressure, inadequate self-care practices, inappropriate shoes, 
and frequent exposure to traumatic events and frequently found peripheral insensate 
neuropathy have been identified as risk factors contributing to foot ulceration in 
diabetic males [26, 27]. Additionally, DFU patients were classified into the PDR or 
NPDR group; our results showed that diabetic males with foot ulcers had a higher 
prevalence of PDR comparatively to females, but this difference was not significant. 
Similarly, a diabetes study from the United Kingdom reported that PDR was more 
prevalent in males than in females [28]. In contrast, a community-based study in 
China showed that diabetic females were associated with increased risk of PDR [29]. 
This gender difference observed in present and previous studies could not identify it 
as a risk factor contributing to PDR in diabetic patients with foot ulceration.
Wagner’s 
grades
No DR, 
N = 10
Mild NPDR, 
N = 11
Moderate 
NPDR
N = 26
Severe 
NPDR
N = 9
PDR, 
N = 169
Total N 
(%)
Grade 1 2 1 3 0 17 23 (10.2)
Grade 2 1 3 3 2 28 37 (16.4)
Grade 3 4 5 11 2 72 94 (41.8)
Grade 4 3 2 9 5 52 71 (31.6)
Grade 5 0 0 0 0 0 0 (0)
Table 3. 
Distribution of diabetic patients with DR according to ulcer grades.
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Importantly, advancing age has been observed as a contributing factor to foot 
ulceration in diabetic patients in many studies [11, 23]. Although prevalence of 
foot ulcers was determined high among advanced age diabetic patients in current 
study, a statistically significant difference was not observed in terms of increasing 
age (≥41 years) of diabetic patients with and without foot ulceration. On the other 
hand, our study demonstrated statistically significant correlation between PDR and 
advanced age of DFU patients. In contrast to this observation, Hwang et al. [11] in 
a recent study failed to show a correlation between PDR and advanced age of DFU 
patients. Similarly, Li and Wang reported lower prevalence of DR in elderly diabetic 
patients and suggested that favorable control of blood glucose, blood pressure, and 
blood lipids effectively prevented the occurrence of DR in diabetic patients [30]. 
Therefore, it seems that high blood glucose levels and elevated systolic blood pres-
sure have contributed to the developing of PDR in elderly DFU patients in current 
study.
Comparatively high prevalence of foot ulcers was observed among diabetic 
patients with diabetes duration more than 10 years in the current study, and this 
observation was significant. A previous study from Sudan supported our observa-
tion [10]. In two different previously conducted diabetic foot studies, the average 
duration of diabetes in DFU patients was 13.2 [31] and 8.2 years [32]. Based on 
current and previous observations, we hypothesize that the lengthy duration of 
diabetes is a significant risk factor for the development of diabetic foot ulceration. 
In addition, Chawla et al. in a study reported that chronic hyperglycemia and 
diabetes duration are among the main contributing factors to development and 
progression of DR in diabetic patients with foot ulcer [33]. The results of the 
present study also showed that lengthy duration of diabetes was a significant risk 
factor in progression of PDR among patients with DFU. In agreement with our 
results, Hwang et al. also reported that the foot ulcer patients with PDR had a 
longer duration of diabetes compared to those with NPDR [11].
5. Conclusion
In summary, the present study showed that a large proportion of advanced age 
patients with longer duration of diabetes had retinopathy and were at substantial 
risk of developing foot ulceration. Therefore, in advanced age DFU patients, and 
particularly those with longer duration of diabetes, early detection of DR and 
timely treatment may decrease the risk of severe vision loss or blindness.
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